3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.685
-0.005 (-0.19%)
Nov 3, 2026, 3:48 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 660.3 million as of November 2, 2026. It is the 26,210th most valuable company in the world and the 1,284th biggest in Hong Kong. Its market cap has decreased by 57.36% in one year.
Market Cap
660.30M
Enterprise Value
339.60M
Revenue
412.66M
Global Rank
Country Rank
#1,284 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 660.30M, a decrease of -90.60%. That is a compound annual growth rate of -45.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 660.30M | -49.51% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhaoke Ophthalmology | 1.10B |
| Cloudbreak Pharma | 1.10B |
| CANbridge Pharmaceuticals | 1.06B |
| Sunho Biologics | 970.43M |
| JW (Cayman) Therapeutics Co. | 901.09M |
| Wuhan YZY Biopharma | 775.40M |
| Brii Biosciences | 707.42M |
| Kintor Pharmaceutical | 666.64M |